CTI Biopharma reported $1.15M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Baxter International BAX:US USD 2.68B 12M
CTI Biopharma CTIC:US USD 1.15M 445K
Novartis NOVN:VX USD 7.18B 396M
Seattle Genetics SGEN:US USD 364.97M 45.62M
Teva Pharmaceutical Industries TEVA:US USD 3.86B 190M
YTE INCY:US USD 120.96M 75.09M